ACTIVE INGREDIENTS
TITANIUM DIOXIDE 18.310%, ZINC OXIDE 1.920%
TITANIUM DIOXIDE 18.310%, ZINC OXIDE 1.920%
MICA,TALC,SILICA,DIMETHICONE,BORON NITRIDE,DIISOSTEARYL MALATE,TRIFLUOROMETHYL C1-4 ALKYL DIMETHICONE,TRIETHOXYCAPRYLYLSILANE,DIPHENYLSILOXY PHENYL TRIMETHICONE, NYLON-12,POLYMETHYL METHACRYLATE,TRIETHYLHEXANOIN,IRON OXIDES(CI 77492), DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE/HEXASTEARATE/HEXAROSINATE,
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER,GLYCERYL CAPRYLATE,POLYGLYCERYL-2 TETRAISOSTEARATE,SILICA DIMETHYL SILYLATE,METHICONE,IRON OXIDES(CI 77491),CAPRYLYL GLYCOL,ALUMINUM MYRISTATE,ALUMINUM HYDROXIDE,DISODIUM STEAROYL GLUTAMATE, TRIMETHYLSILOXYSILICATE,ALUMINUM DIMYRISTATE,FRAGRANCE(PARFUM),MYRISTIC ACID, PHYTOSTERYL/OCTYLDODECYL LAUROYL GLUTAMATE,TOCOPHERYL ACETATE,IRON OXIDES(CI 77499),ALUMINA,AQUA/WATER/EAU,CALCIUM CARBONATE,HYDROXYAPATITE,ZEA MAYS (CORN) STARCH,PISTACIA LENTISCUS (MASTIC) GUM,PROPOLIS WAX,ROYAL JELLY EXTRACT,ACETYL HEXAPEPTIDE-8
Sunscreen agent
For extral use only
UV exposure from the sun increases the risk of skin cancer, premature skin aging and other skin damage.
It is important to decrease UV exporsure by limiting time in the sun, wearing protective clothing, and using a sunscreen.
When using this product, keep out of eyes. Rinse water to remove.
Stop use and ask a doctor, if rash or irritation develops and lasts.
Do not use
• Areas of eczema, skin inflammation, or after injury
When using this produt
• Discontinue use if irritation or rash appear.
• Keep out of eyes
• Rinse with water to remove
Ask a doctor before use if you have
• Poor blood circulation
• Irritated skin
• Any area that is infected or reddened
• Diabetes
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center right away
Uses:
• Provides moderate protection against adverse effects of the sun.
• Higher SPF gives more sunburn protection.
• Helps prevent sunburn.
• Effective for the skin highly sensitive to sunburn.
Directions
• Apply liberally before sun exporsure.
• Children under 6 months of age: ask a doctor.
• Reapply as needed or after towel drying, swimming or perspiring.
• Not intended for protection while sunbathing.
• Store at 20-25 degrees C (68-77 degrees F)
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52257-1270 | 52257-1270-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
| MICA | V8A1AW0880 | IACT |
| TALC | 7SEV7J4R1U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| TALC | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bf60af5e-cd4e-41ee-9beb-405e0f123b47 | 58499640-45fd-48fb-b47b-9b1636fb9f0c | 2021-10-29 | Warnings | 58499640-45fd-48fb-b47b-9b1636fb9f0c |
Adverse event summaries are temporarily unavailable. Other product information remains available.